Provectus Biopharmaceuticals (PVCT) Q3 2019 Earnings

31DecConfirmed
May 19
Aug 19
Nov 19
Q3 2019
-0.01
-0.01
-0.01
-0

Details

Expected EPS
N/A
Actual EPS
-0.004
Surprise EPS
-0
Surprise Percent
+∞%

Description

Provectus Biopharmaceuticals (PVCT) has reported earnings of -0.004 per share for Q3 2019.

0 Comments

Share your thoughts